Genzyme Corp
Article Abstract:
The price appreciation potential of the shares of Genzyme Corp. for the years 2010-2012 is discussed. The Cambridge, Massachusetts-based biotechnology company offers pharmaceutical products, biotherapeutics, surgical products, diagnostic products, and services such as genetic testing.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
Pharmaceutical preparations, Drugs, Evaluation, Biotechnology industry, Biotechnology industries, Stocks, Stock prices, Genzyme Corp., GENZ
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Sicor Inc
Article Abstract:
Sicor Inc. 's had a slight increase in share earnings but operating earnings may slow down from 2004 onwards. Owing to some products having commercial viability, generic filings may pay off out to 2006-2008.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
United States, Sales, profits & dividends, Forecasts, trends, outlooks, Financial management, Labor Distribution by Employer, Finance, Company investment, Investments, Statistics, Company sales and earnings, Company earnings/profit, Sicor Inc., SCRI, Company business forecast/projection, Company forecasts
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Pharmaceutical industry, Securities, Company securities
Similar abstracts:
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.